Jubilant Pharmova Limited - Company Profile

It is a pharma public limited company based in U P, Uttar Pradesh, India, established in 1978.
1978 U P, Uttar Pradesh, India Active
Last Updated:
Access Report
About Jubilant Pharmova Limited

Jubilant Pharmova Limited, a active public limited company, was established on 21 June 1978 in U P, Uttar Pradesh, India. Engaging in api manufacturers within the professional, scientific and technical sector, it holds CIN: L24116UP1978PLC004624. Registered under ROC Roc Kanpur. it is listed on BSE: 530019 and NSE: JUBLPHARMA. It has an authorized capital of ₹143.02 Cr and a paid-up capital of ₹15.93 Cr.

Formerly known as Vam Organic Chemicals Limited, Jubilant Organosys Limited. It upholds a compliant status. In 2023, it reported revenue of ₹948.01 Cr and a net worth of ₹2,414.55 Cr. Employing 1,055 professional, Its leadership includes Arvind Chokhany (Whole-Time Director), Shyam Sunder Bhartia (Director), Hari Shanker Bhartia (Director). Past directors included Rajesh Kumar Srivastava, Arvind Chokhany, Shyam Sunder Bhartia. It holds ₹360.00 Cr open charges and ₹9,185.57 Cr settled loans. Its latest AGM occurred on 29 August 2025, with the balance sheet filed on 31 March 2025. It is based at Bhartiagram Gajraulajyotiba Phoolay Nagar, U P, Uttar Pradesh, 244223.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24116UP1978PLC004624

  • Registration Number

    004624

  • Incorporation Date

    21 June 1978

  • Authorized Capital

    ₹143.02 Cr

  • Paid-Up Capital

    ₹15.93 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Listed (BSE: 530019, NSE: JUBLPHARMA)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 143.02 Cr
  • Paid Up Capital ₹ 15.93 Cr
  • Company Age 48 Year, 16 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 360.00 Cr
  • Satisfied Charges ₹ 9,185.57 Cr
  • Revenue Growth **** 343.79%
  • Profit Growth **** -36.46%
  • Ebitda **** 147.53%
  • Net Worth 88.37%
  • Total Assets **** 64.44%
Company report

Jubilant Pharmova Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Jubilant Pharmova Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jubilant Pharmova Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Chokhany Whole-Time Director 01 Apr 2021 Current
Shyam Sunder Bhartia Director 21 Jun 1978 Current
Hari Shanker Bhartia Director 01 Nov 1983 Current
Arun Kumar Sharma Cfo 01 Oct 2025 Current
Shivpriya Nanda Director 01 Apr 2024 Current
Shirish Gundopant Belapure Director 07 Mar 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Sep 2018 Past
Pramod Abcsdd Additional Director 22 Sep 2021 Past
Pramod Abcsdd Managing Director 25 Mar 2015 Past
Pramod Abcsdd Managing Director 31 May 2023 Past
Pramod Abcsdd Whole-Time Director 03 Nov 2009 Past
Pramod Abcsdd Additional Director 01 Nov 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jubilant Pharmova.

Jubilant Pharmova Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 343.79% increase. The company also saw a substantial fall in profitability, with a 36.46% decrease in profit. The company's net worth Soared by an impressive increase of 88.37%.

Jubilant Pharmova revenue growth over time
Jubilant Pharmova profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 343.79%
*******
*******
*******
*******
Revenue from Operations
*******
 823.23%
*******
*******
*******
*******
Total Assets
*******
 64.44%
*******
*******
*******
*******
Profit or Loss
*******
 -36.46%
*******
*******
*******
*******
Net Worth
*******
 88.37%
*******
*******
*******
*******
EBITDA
*******
 147.53%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jubilant Pharmova?

In 2022, Jubilant Pharmova had a promoter holding of 50.68% and a public holding of 49.33%. The company had 7 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,600,000,000.00

Satisfied Charges

₹91,855,680,000.00

Charges Breakdown by Lending Institutions
  • Others : 210.00 Cr
  • Hdfc Bank Limited : 100.00 Cr
  • Yes Bank Limited : 50.00 Cr
Latest Charge Details
Date Lender Amount Status
29 Aug 2025 Others ₹50.00 Cr Open
26 Feb 2024 Hdfc Bank Limited ₹100.00 Cr Open
28 Aug 2023 Others ₹100.00 Cr Open
23 Mar 2023 Yes Bank Limited ₹50.00 Cr Open
15 Feb 2023 Others ₹60.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Jubilant Pharmova?

Jubilant Pharmova has a workforce of 1055 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jubilant Pharmova, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Pharmova's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jubilant Pharmova
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 25 Jul 2022 via Charge ID 100600986 with Axis Bank Limited was fully satisfied on 14 Nov 2025. was documented.

  • Charges

    A charge registered on 20 Sep 2022 via Charge ID 100616639 with Others was fully satisfied on 28 Oct 2025. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 50.00 Cr registered on 29 Aug 2025 with Charge ID 101158066 was modified on 13 Oct 2025. was recorded as a recent event.

  • Director Appointment

    Arun Kumar Sharma was appointed as a CFO was appointed as a CFO on 01 Oct 2025 & has been associated with this company since 9 months 6 days . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101158066 was registered on 29 Aug 2025. was documented.

  • Annual General Meeting

    The activity Jubilant Pharmova Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Jubilant Pharmova Limited?

The CIN of Jubilant Pharmova Limited is L24116UP1978PLC004624.

Where is Jubilant Pharmova Limited headquartered?

Jubilant Pharmova Limited is headquartered at Bhartiagram Gajraulajyotiba Phoolay Nagar, U P, Uttar Pradesh, 244223.

When was Jubilant Pharmova Limited incorporated?

Jubilant Pharmova Limited was incorporated on 21 June 1978.

Who are the current directors of Jubilant Pharmova Limited?

The current directors of Jubilant Pharmova Limited are

What is the primary industry of Jubilant Pharmova Limited?

The primary industry of Jubilant Pharmova Limited is Professional, Scientific And Technical.

Is Jubilant Pharmova Limited a listed company?

Jubilant Pharmova Limited is listed. It is listed on BSE: 530019 and NSE: JUBLPHARMA.

What is the capital structure of Jubilant Pharmova Limited?

The authorized capital of Jubilant Pharmova Limited is ₹143.02 Cr, and the paid-up capital is ₹15.93 Cr.

What is the compliance status of Jubilant Pharmova Limited?

The compliance status of Jubilant Pharmova Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available